Jump to main content
Jump to site search

Issue 4, 2011
Previous Article Next Article

A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment

Author affiliations

Abstract

The tumor microenvironment provides a rich source of potential targets for selective therapeutic intervention with properly designed anticancer agents. Significant physiological differences exist between the microvessels that nourish tumors and those that supply healthy tissue. Selective drug-mediated damage of these tortuous and chaotic microvessels starves a tumor of necessary nutrients and oxygen and eventually leads to massive tumor necrosis. Vascular targeting strategies in oncology are divided into two separate groups: angiogenesis inhibiting agents (AIAs) and vascular disrupting agents (VDAs). The mechanisms of action between these two classes of compounds are profoundly distinct. The AIAs inhibit the actual formation of new vessels, while the VDAs damage and/or destroy existing tumor vasculature. One subset of small-molecule VDAs functions by inhibiting the assembly of tubulin into microtubules, thus causing morphology changes to the endothelial cells lining the tumor vasculature, triggered by a cascade of cell signaling events. Ultimately this results in catastrophic damage to the vessels feeding the tumor. The rapid emergence and subsequent development of the VDA field over the past decade has led to the establishment of a synergistic combination of preclinical state-of-the-art tumor imaging and biological evaluation strategies that are often indicative of future clinical efficacy for a given VDA. This review focuses on an integration of the appropriate biochemical and biological tools necessary to assess (preclinically) new small-molecule, tubulin active VDAs for their potential to be clinically effective anticancer agents.

Graphical abstract: A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment

Back to tab navigation

Publication details

The article was received on 08 Nov 2010, accepted on 27 Dec 2010 and first published on 14 Feb 2011


Article type: Perspective
DOI: 10.1039/C0IB00135J
Citation: Integr. Biol., 2011,3, 375-387
  •   Request permissions

    A perspective on vascular disrupting agents that interact with tubulin: preclinical tumor imaging and biological assessment

    R. P. Mason, D. Zhao, L. Liu, M. L. Trawick and K. G. Pinney, Integr. Biol., 2011, 3, 375
    DOI: 10.1039/C0IB00135J

Search articles by author

Spotlight

Advertisements